Elevance health inc ELV.US Overview Analysis
ELV AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock holds a moderate value rating. If you have positions, consider retaining; for new ones, wait for a value score above 4.
ELV Current Performance
0.91%
Elevance health inc
2.03%
Avg of Sector
0.54%
S&P500
Top 10 High Relevance to ELV
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
UNH | Unitedhealth group inc | 3 | 5 | 4 | 4 | 4 | |
CNC | Centene corporation | 3 | 3 | 4 | 3 | 1 | |
MOH | Molina healthcare, inc. | 4 | 4 | 4 | 3 | 1 | |
CI | Cigna group | 4 | 5 | 5 | 3 | 4 | |
HUM | Humana inc | 2 | 2 | 1 | 3 | 3 |
- UNH Unitedhealth group incValue 3Trend 5Swing Trading 4Whale Interest 4Dividend 4See more
ELV Profile
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.